Declining in liver stiffness cannot indicate fibrosis regression in patients with chronic hepatitis B: A 78 ‐week prospective study

ConclusionsIn CHB patients receiving 78 ‐week antiviral treatment, LSM could diagnosis different liver fibrosis stages, decrease in absolute LSM value could reflect the remission of liver inflammation, and baseline Ishak fibrosis score was the only predictor for 78‐week fibrosis reversion.

Source: Journal of Gastroenterology and Hepatology - November 8, 2018 Category: Gastroenterology Authors: Xiao ‐Qin Dong, Zhao Wu, Jun Li, Gui‐Qiang Wang, Hong Zhao, China HepB‐Related Fibrosis Assessment Research Group Tags: Hepatology Source Type: research